Dominic Wei Ting Yap
Overview
Explore the profile of Dominic Wei Ting Yap including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhao J, Syn N, Tan B, Yap D, Teo C, Chan Y, et al.
BMC Med Res Methodol
. 2022 Apr;
22(1):93.
PMID: 35369867
Background: Data from certain subgroups of clinical interest may not be presented in primary manuscripts or conference abstract presentations. In an effort to enable secondary data analyses, we propose a...
12.
Leen A, Yap D, Teo C, Tan B, Molassiotis A, Ishiguro H, et al.
Front Oncol
. 2022 Jan;
11:763229.
PMID: 35070969
Background: Paclitaxel-induced peripheral neuropathy (PIPN) is a disabling side effect of paclitaxel with few effective preventive strategies. We aim to determine the efficacy of pharmacological and non-pharmacological neuroprotective interventions in...
13.
Autophagy and ncRNAs: Dangerous Liaisons in the Crosstalk between the Tumor and Its Microenvironment
Ling Eng G, Zheng Y, Yap D, Teo A, Cheong J
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008183
Autophagy is a fundamental cellular homeostasis mechanism known to play multifaceted roles in the natural history of cancers over time. It has recently been shown that autophagy also mediates the...
14.
Zhao J, Yap D, Chan Y, Tan B, Teo C, Syn N, et al.
J Clin Oncol
. 2021 Dec;
40(4):392-402.
PMID: 34860570
Purpose: The US Food and Drug Administration has granted regulatory approval for the use of nivolumab-an immune checkpoint inhibitor (ICI)-in the first-line treatment of advanced gastric or esophageal adenocarcinoma (GEAC),...
15.
Tan N, Yap D, Tan B, Teo Y, Tan E, Chan J, et al.
Sleep Med
. 2021 Nov;
88:213-220.
PMID: 34794048
Background: Melanoma is the most aggressive and lethal form of skin cancer. While emerging in-vivo evidence suggests that intermittent hypoxia, a hallmark feature of obstructive sleep apnea (OSA), may induce...
16.
Cheong A, Tan B, Teo Y, Tan N, Yap D, Sia C, et al.
Ann Am Thorac Soc
. 2021 Nov;
19(3):469-475.
PMID: 34792438
In 2020, lung cancer was the leading cause of cancer deaths and the most common cancer in men. Although obstructive sleep apnea (OSA) has been postulated to be carcinogenic, epidemiological...
17.
Tan B, Teo Y, Tan N, Yap D, Sundar R, Lee C, et al.
J Clin Sleep Med
. 2021 Nov;
18(5):1427-1440.
PMID: 34755597
Study Objectives: Biological models suggest that obstructive sleep apnea (OSA) is potentially carcinogenic. We aimed to clarify the inconsistent epidemiological literature by considering various traditional and novel OSA severity indices....